Actavis Laboratories Fl, Inc. v. United States
Federal Circuit Clarifies Medicare Part D 'Substantially All' Drug Reimbursement Rule
cafc · 2025-03-21 · Defendant Win · Impact: 40/100
Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...